SOPs » N

non-Hodgkin's lymphoma

SOPs » N

non-Hodgkin's lymphoma

Category: Neoplasms

Current SOPs

SOP Numbers Date of Commencement Incorporated Material Status
Reasonable Hypothesis
28/2010 18/09/2017 Guide to Calculation of Cumulative Equivalent Dose ARPANSA 2 August 2017 Current Compilation
SOP Numbers Date of Commencement Incorporated Material Status
Balance of Probabilities
29/2010 29/2010 12/05/2010 Current Principal

Past Versions of SOPs

SOP Numbers Date of Commencement Status
Reasonable Hypothesis Balance of Probabilities
58/2017 58/2017   18/09/2017 Current Amendment
40/2016 40/2016   04/04/2016 Current Amendment
93/2015 93/2015   20/07/2015 Current Amendment
86/2014 86/2014 87/2014 87/2014 22/09/2014 Current Amendment
57/2014 57/2014   07/05/2014 Current Amendment
28/2010 28/2010 29/2010 29/2010 12/05/2010 Current Principal
37/2003 38/2003 20/08/2003 Revoked Principal
80/1999 81/1999 10/11/1999 Revoked Principal
44/1999 45/1999 30/06/1999 Revoked Principal
69/1997 70/1997 17/09/1997 Revoked Principal
175/1996 176/1996 18/12/1996 Revoked Principal
109/1996 110/1996 28/08/1996 Revoked Principal
79/1994 80/1994 21/12/1994 Revoked Principal

Other Information

Subject Documents Relevant SOPs Date Comment
Explanatory Notes tabled in Houses of Parliament Explanatory statement 28/2010 - non-Hodgkin's lymphoma - RH Explanatory statement 29/2010 - non-Hodgkin's lymphoma - BOP 28/2010 29/2010 12/05/2010  
Amendment Explanatory Statements tabled in Houses of Parliament Amendment Determination Explanatory Statement No 58 of 2017 Veterans Entitlements SOPs Cumulative Equivalent Dose 18 September 2017 58/2017 18/09/2017  
SMRC Declaration - (No. 26) SMRC Declaration - non-Hodgkin's lymphoma SMRC Declaration - non-Hodgkin's lymphoma

28/2010 & 29/2010, as amended

27/04/2015 Amendment SOP No. 93/2015 determined as per SMRC direction
RMA Investigation RMA Declaration - non-Hodgkin's lymphoma RMA Declaration - non-Hodgkin's lymphoma

28/2010 & 29/2010

24/04/2014 RMA determined not to amend BOP SOP after examining 'ionizing radiation' and 'benzene exposure'. Amendment SOP No. 57/2014 determined.
Top